Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1174158

Adropin Serum Levels in Patients with Primary Sjögren’s Syndrome


Janković Danolić, Marijana; Perković, Dijana; Petrić, Marin; Barišić, Igor; Gugo, Katarina; Božić, Joško
Adropin Serum Levels in Patients with Primary Sjögren’s Syndrome // Biomolecules, 11 (2021), 9; 1296, 11 doi:10.3390/biom11091296 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1174158 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Adropin Serum Levels in Patients with Primary Sjögren’s Syndrome

Autori
Janković Danolić, Marijana ; Perković, Dijana ; Petrić, Marin ; Barišić, Igor ; Gugo, Katarina ; Božić, Joško

Izvornik
Biomolecules (2218-273X) 11 (2021), 9; 1296, 11

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
primary Sjögren’s syndrome ; adropin ; endothelial dysfunction ; anti SSA/Ro52 antibodies ; SSDDI

Sažetak
Primary Sjögren’s syndrome (pSS) patients have higher prevalence of endothelial dysfunction and premature atherosclerosis. Recent studies investigated adropin, a secretory protein that can regulate lipid metabolism and insulin resistance and protect endothelial cells’ function and that has an anti-inflammatory effect. The aim of this study was to determine adropin levels in pSS patients compared to healthy controls. Additional goals were exploring the correlation between adropin and several metabolic and immunological parameters in pSS, including disease specific antibodies, EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI), and Sjögren’s Syndrome Disease Damage Index (SSDDI). This research included 52 pSS patients and 52 healthy controls. pSS patients have significantly higher adropin levels compared to the control group (3.76 ± 0.68 vs. 3.14 ± 0.69 ng/mL, p < 0.001). Correlation analysis showed that adropin levels in pSS patients have positive correlation with high-density lipoprotein (HDL) (r = 0.290, p = 0.036) and anti SSA/Ro52 antibodies (r = 0.307, p = 0.026) and negative correlation with SSDDI (r = −0.401, p = 0.003). Multivariant linear regression showed that adropin levels are independently associated with HDL (β ± SE, 0.903 ± 0.283, p = 0.002) and SSDDI (β ± SE, −0.202 ± 0.073, p = 0.008). Our findings imply that adropin could be involved in the pathophysiology of pSS, yet it remains to be elucidated in future studies whether adropin has a protective or detrimental role in this setting.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
KBC Split,
Medicinski fakultet, Split

Profili:

Avatar Url Dijana Perković (autor)

Avatar Url Katarina Gugo (autor)

Avatar Url Joško Božić (autor)

Avatar Url Igor Barišić (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Janković Danolić, Marijana; Perković, Dijana; Petrić, Marin; Barišić, Igor; Gugo, Katarina; Božić, Joško
Adropin Serum Levels in Patients with Primary Sjögren’s Syndrome // Biomolecules, 11 (2021), 9; 1296, 11 doi:10.3390/biom11091296 (međunarodna recenzija, članak, znanstveni)
Janković Danolić, M., Perković, D., Petrić, M., Barišić, I., Gugo, K. & Božić, J. (2021) Adropin Serum Levels in Patients with Primary Sjögren’s Syndrome. Biomolecules, 11 (9), 1296, 11 doi:10.3390/biom11091296.
@article{article, author = {Jankovi\'{c} Danoli\'{c}, Marijana and Perkovi\'{c}, Dijana and Petri\'{c}, Marin and Bari\v{s}i\'{c}, Igor and Gugo, Katarina and Bo\v{z}i\'{c}, Jo\v{s}ko}, year = {2021}, pages = {11}, DOI = {10.3390/biom11091296}, chapter = {1296}, keywords = {primary Sj\"{o}gren’s syndrome, adropin, endothelial dysfunction, anti SSA/Ro52 antibodies, SSDDI}, journal = {Biomolecules}, doi = {10.3390/biom11091296}, volume = {11}, number = {9}, issn = {2218-273X}, title = {Adropin Serum Levels in Patients with Primary Sj\"{o}gren’s Syndrome}, keyword = {primary Sj\"{o}gren’s syndrome, adropin, endothelial dysfunction, anti SSA/Ro52 antibodies, SSDDI}, chapternumber = {1296} }
@article{article, author = {Jankovi\'{c} Danoli\'{c}, Marijana and Perkovi\'{c}, Dijana and Petri\'{c}, Marin and Bari\v{s}i\'{c}, Igor and Gugo, Katarina and Bo\v{z}i\'{c}, Jo\v{s}ko}, year = {2021}, pages = {11}, DOI = {10.3390/biom11091296}, chapter = {1296}, keywords = {primary Sj\"{o}gren’s syndrome, adropin, endothelial dysfunction, anti SSA/Ro52 antibodies, SSDDI}, journal = {Biomolecules}, doi = {10.3390/biom11091296}, volume = {11}, number = {9}, issn = {2218-273X}, title = {Adropin Serum Levels in Patients with Primary Sj\"{o}gren’s Syndrome}, keyword = {primary Sj\"{o}gren’s syndrome, adropin, endothelial dysfunction, anti SSA/Ro52 antibodies, SSDDI}, chapternumber = {1296} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font